In addition, patients with CD44 rs187116 AG and AA genotype reached borderline significance with median OS of 2.5 and 4.6 months, respectively (95% CI, 2.33- 2.67 and 3.63- 5.57 months) compared to 2.3 months (95% CI, 1.97- 2.63 months) regarding homozygous patients for GG genotype (p< 0.0001, log-rank test).
← all excerpts
Association of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer Patients
1
—
—